DODGE & COX, a registered investment adviser, initiated a new position in CVS Health Corporation (NYSE:CVS) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 62,509,988 shares of the Healthcare company, valued at approximately $5.0B as of the filing date.
CVS Health Corporation's stock currently trades at $75.97 with a market capitalization of $102.6B.


